| pubmed-article:11687836 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C0019120 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C0443286 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C1579762 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C0009491 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:11687836 | lifeskim:mentions | umls-concept:C0141950 | lld:lifeskim |
| pubmed-article:11687836 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11687836 | pubmed:dateCreated | 2001-11-5 | lld:pubmed |
| pubmed-article:11687836 | pubmed:abstractText | Intranasal administration of Semax, peptide Pro-Gly-Pro, and a mixture of peptides Pro-Gly+Gly-Pro to rats for 5 days enhanced anticoagulant and fibrinolytic potential of the plasma (total fibrinolytic activity and plasmin and plasminogen activator activities) and decreased antiplasmin concentration. Semax and Pro-Gly-Pro decreased the weight of thrombi during experimental thrombosis. | lld:pubmed |
| pubmed-article:11687836 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11687836 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11687836 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11687836 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:11687836 | pubmed:issn | 0007-4888 | lld:pubmed |
| pubmed-article:11687836 | pubmed:author | pubmed-author:AshmarinI PIP | lld:pubmed |
| pubmed-article:11687836 | pubmed:author | pubmed-author:LyapinaL ALA | lld:pubmed |
| pubmed-article:11687836 | pubmed:author | pubmed-author:CherkasovaK... | lld:pubmed |
| pubmed-article:11687836 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11687836 | pubmed:volume | 132 | lld:pubmed |
| pubmed-article:11687836 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11687836 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11687836 | pubmed:pagination | 625-6 | lld:pubmed |
| pubmed-article:11687836 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:meshHeading | pubmed-meshheading:11687836... | lld:pubmed |
| pubmed-article:11687836 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11687836 | pubmed:articleTitle | Comparative study of modulatory effects of Semax and primary proline-containing peptides on hemostatic reactions. | lld:pubmed |
| pubmed-article:11687836 | pubmed:affiliation | Department of Human and Animal Physiology, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow. chk99@mail.ru | lld:pubmed |
| pubmed-article:11687836 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11687836 | pubmed:publicationType | Comparative Study | lld:pubmed |
